SPRAVATO®
(esketamine)
Medical inquiries
This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.
SPRAVATO® (esketamine)
Medical Information
Esketamine nasal spray versus psychoactive comparator for rapid reduction of depressive symptoms in adolescents at imminent suicide risk
Last updated: 05/21/2023
SPRAVATO® (esketamine) nasal spray is not approved for use in pediatric patients. This poster addresses an investigational use of the product.
The following information is provided because of your specific unsolicited request and is not intended as an endorsement of any usage not contained in the Prescribing Information. For complete information, please refer to the full Prescribing Information including Boxed Warning.